These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 31119107)

  • 41. Characteristics and critical function of CD8+ T cells in the Toxoplasma-infected brain.
    Landrith TA; Harris TH; Wilson EH
    Semin Immunopathol; 2015 May; 37(3):261-70. PubMed ID: 25898888
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Induction of CD4+ and CD8+ T cell responses in efferent lymph responding to Toxoplasma gondii infection: analysis of phenotype and function.
    Innes EA; Panton WR; Sanderson A; Thomson KM; Wastling JM; Maley S; Buxton D
    Parasite Immunol; 1995 Mar; 17(3):151-60. PubMed ID: 7792099
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Naïve CD8 T cell IFNγ responses to a vacuolar antigen are regulated by an inflammasome-independent NLRP3 pathway and Toxoplasma gondii ROP5.
    Kongsomboonvech AK; Rodriguez F; Diep AL; Justice BM; Castallanos BE; Camejo A; Mukhopadhyay D; Taylor GA; Yamamoto M; Saeij JPJ; Reese ML; Jensen KDC
    PLoS Pathog; 2020 Aug; 16(8):e1008327. PubMed ID: 32853276
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The Toxoplasma gondii peptide AS15 elicits CD4 T cells that can control parasite burden.
    Grover HS; Blanchard N; Gonzalez F; Chan S; Robey EA; Shastri N
    Infect Immun; 2012 Sep; 80(9):3279-88. PubMed ID: 22778097
    [TBL] [Abstract][Full Text] [Related]  

  • 45. T cell blastogenic responses to Toxoplasma gondii trophozoites among HIV-infected patients.
    Carrega G; Canessa A; Argenta P; Cruciani M; Bassetti D
    AIDS Res Hum Retroviruses; 1995 Jun; 11(6):741-6. PubMed ID: 7576934
    [TBL] [Abstract][Full Text] [Related]  

  • 46. TAP-1 indirectly regulates CD4+ T cell priming in Toxoplasma gondii infection by controlling NK cell IFN-gamma production.
    Goldszmid RS; Bafica A; Jankovic D; Feng CG; Caspar P; Winkler-Pickett R; Trinchieri G; Sher A
    J Exp Med; 2007 Oct; 204(11):2591-602. PubMed ID: 17923502
    [TBL] [Abstract][Full Text] [Related]  

  • 47. CD8+ T cell immunity in an encephalitis model of Toxoplasma gondii infection.
    Hwang S; Khan IA
    Semin Immunopathol; 2015 May; 37(3):271-9. PubMed ID: 25944514
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Rudolf-Virchow Prize 1998. Award lecture. Toxoplasmosis: a model infection for studying systemic and intracerebral immune reactions].
    Deckert-Schlüter M
    Verh Dtsch Ges Pathol; 1998; 82():9-22. PubMed ID: 10095413
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Absence of both IL-7 and IL-15 severely impairs the development of CD8 T cell response against Toxoplasma gondii.
    Bhadra R; Guan H; Khan IA
    PLoS One; 2010 May; 5(5):e10842. PubMed ID: 20520779
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Intrinsic expression of Nod2 in CD4+ T lymphocytes is not necessary for the development of cell-mediated immunity and host resistance to Toxoplasma gondii.
    Caetano BC; Biswas A; Lima DS; Benevides L; Mineo TW; Horta CV; Lee KH; Silva JS; Gazzinelli RT; Zamboni DS; Kobayashi KS
    Eur J Immunol; 2011 Dec; 41(12):3627-31. PubMed ID: 22002196
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Rhoptry and Dense Granule Secreted Effectors Regulate CD8
    Rommereim LM; Fox BA; Butler KL; Cantillana V; Taylor GA; Bzik DJ
    Front Immunol; 2019; 10():2104. PubMed ID: 31555296
    [No Abstract]   [Full Text] [Related]  

  • 52. Previous Infection with Plasmodium berghei Confers Resistance to Toxoplasma gondii Infection in Mice.
    Lee DH; Chu KB; Kang HJ; Lee SH; Quan FS
    Korean J Parasitol; 2019 Apr; 57(2):93-99. PubMed ID: 31104401
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Determination of a Key Antigen for Immunological Intervention To Target the Latent Stage of
    Sa Q; Ochiai E; Tiwari A; Mullins J; Shastri N; Mercier C; Cesbron-Delauw MF; Suzuki Y
    J Immunol; 2017 Jun; 198(11):4425-4434. PubMed ID: 28446567
    [No Abstract]   [Full Text] [Related]  

  • 54. A pathway to cure chronic infection with Toxoplasma gondii through immunological intervention.
    Suzuki Y
    Parasitol Int; 2021 Apr; 81():102259. PubMed ID: 33271362
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Presentation of Toxoplasma gondii antigens via the endogenous major histocompatibility complex class I pathway in nonprofessional and professional antigen-presenting cells.
    Dzierszinski F; Pepper M; Stumhofer JS; LaRosa DF; Wilson EH; Turka LA; Halonen SK; Hunter CA; Roos DS
    Infect Immun; 2007 Nov; 75(11):5200-9. PubMed ID: 17846116
    [TBL] [Abstract][Full Text] [Related]  

  • 56. CD4+ T cells are trigger and target of the glucocorticoid response that prevents lethal immunopathology in toxoplasma infection.
    Kugler DG; Mittelstadt PR; Ashwell JD; Sher A; Jankovic D
    J Exp Med; 2013 Sep; 210(10):1919-27. PubMed ID: 23980098
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Functional characterization of in vivo effector CD4(+) and CD8(+) T cell responses in acute Toxoplasmosis: an interplay of IFN-gamma and cytolytic T cells.
    Jongert E; Lemiere A; Van Ginderachter J; De Craeye S; Huygen K; D'Souza S
    Vaccine; 2010 Mar; 28(13):2556-64. PubMed ID: 20117266
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Treatment with soluble interleukin-15Ralpha exacerbates intracellular parasitic infection by blocking the development of memory CD8+ T cell response.
    Khan IA; Moretto M; Wei XQ; Williams M; Schwartzman JD; Liew FY
    J Exp Med; 2002 Jun; 195(11):1463-70. PubMed ID: 12045244
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The temperature-sensitive mutants of Toxoplasma gondii and ocular toxoplasmosis.
    Lu F; Huang S; Kasper LH
    Vaccine; 2009 Jan; 27(4):573-80. PubMed ID: 19026704
    [TBL] [Abstract][Full Text] [Related]  

  • 60. A Lower Dose of Infection Generates a Better Long-Term Immune Response against Toxoplasma gondii.
    Moretto MM; Chen J; Meador M; Phan J; Khan IA
    Immunohorizons; 2023 Feb; 7(2):177-190. PubMed ID: 36883950
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.